Goat milk protein study for children with milk-triggered esophagus inflammation
Part of Blood & lymphatic, Digestive system, Immune system & allergy clinical trials.
This trial tests whether goat milk protein is tolerated and safe for kids with eosinophilic esophagitis (EoE) whose symptoms improve when cow milk is stopped and come back when cow milk is added again. It may help some families find an alternative to cow milk, but you must meet specific “milk trigger” and allergy-safety requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has EoE and is 17.5 years old or younger when joining.
- Cow milk must clearly trigger EoE: symptoms improve when cow milk is removed, then histology (tissue inflammation on scope) improves and later returns after cow milk is reintroduced.
- Before starting, the endoscopy must show the esophagus is in remission while on a milk-free diet.
- Your child must be able to participate with consent: parents/guardians can consent, and kids older than 10 also give joint consent.
- Cow milk (and possibly goat milk) allergy must be ruled out—especially IgE-type milk allergy; if allergy testing is positive, a specialist must clear them after a supervised goat milk challenge.
- If your child uses inhaled steroid medicines for the lungs, it must not be more than 5 days per month during the trial period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether heating cow's milk or hen's egg (like baking them) can help children with EoE stay in remission. It's for children whose EoE is triggered by these foods and who are currently doing well (no active EoE).
This study looks at how often children with eosinophilic esophagitis (a type of food allergy causing esophagus swelling) have immediate symptoms after eating certain foods. It may help doctors better understand and manage the condition.
This Phase 1/2 study tests EP-104GI in adults with eosinophilic esophagitis (EoE), a condition where certain immune cells cause inflammation in the food pipe. It may help improve symptoms and inflammation, and the study also includes a part where people who do well can switch to the active drug.
This study looks at children ages 0–18 with eosinophilic gut disorders (EGIDs) to better understand these conditions and how they are managed. It may help doctors improve care by comparing real-world information from patients followed at participating hospitals.
This study looks at how inflamed the esophagus is in children who have eosinophilic esophagitis (EoE). It may help doctors better understand what’s driving symptoms like trouble swallowing and food getting stuck.
This trial tests an intervention meant to improve how well adults with eosinophilic esophagitis (EoE) follow their ongoing treatment plan. It may help you stay on your medicine and get better symptom control by making adherence easier.
Hear when a new Eosinophilic Esophagitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.